Cargando…

Adjunctive Pharmacotherapy for Elective Direct Current Cardioversion in Patients With Atrial Fibrillation

BACKGROUND: Direct current cardioversion (DCCV) can restore sinus rhythm in patients with atrial fibrillation (AF), but the long term efficacy is poor. Pharmacological therapies may improve the initial success of the procedure, but whether long term maintenance of sinus rhythm can be improved is unc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirt, Liam S., Gobin, Maya S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5358207/ https://www.ncbi.nlm.nih.gov/pubmed/28348681 http://dx.doi.org/10.4021/cr198w

Ejemplares similares

Absence of significant myocardial injury following elective direct current cardioversion for atrial fibrillation
por: Lobo, Ronstan, et al.
Publicado: (2022)

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
por: Jacobs, Maartje S., et al.
Publicado: (2017)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Sternal fracture after elective electrical cardioversion of atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2010)

Early Risk of Stroke in Patients Undergoing Acute Versus Elective Cardioversion for Atrial Fibrillation
por: Forslund, Tomas, et al.
Publicado: (2021)

Current Status of Internal Cardioversion in Atrial Fibrillation
por: Plewan, Andreas, et al.
Publicado: (2002)

The Impact of Right Atrial Size to Predict Success of Direct Current Cardioversion in Patients With Persistent Atrial Fibrillation
por: Döring, Christoph, et al.
Publicado: (2023)

Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation
por: Son, Nguyen Khac Le, et al.
Publicado: (2020)

Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion
por: Demirel, Ozan, et al.
Publicado: (2023)

Feasibility and safety of the direct current cardioversion at the time of left atrial appendage occlusion for patients with atrial fibrillation
por: Meng, Xian Sai, et al.
Publicado: (2023)

Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion
por: Beaty, Elijah H., et al.
Publicado: (2022)

Left Atrial Appendage Thrombosis During Therapy with Rivaroxaban in Elective Cardioversion for Permanent Atrial Fibrillation
por: Serra, Walter, et al.
Publicado: (2015)

Comparing the delay with different anticoagulants before elective electrical cardioversion for atrial fibrillation/flutter
por: Wall, Christopher, et al.
Publicado: (2019)

Comparison of clinical outcomes of Ibutilide-guided cardioversion and direct current synchronized cardioversion after radiofrequency ablation of persistent atrial fibrillation
por: Liu, Xing, et al.
Publicado: (2023)

Trends and Outcomes of Oral Anticoagulation With Direct Current Cardioversion for Atrial Fibrillation/Flutter at an Academic Medical Center
por: Arshad, Samiullah, et al.
Publicado: (2022)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
por: Deuling, J. H. H., et al.
Publicado: (2011)

A review of direct current cardioversions for atrial arrhythmia.
por: Johnston, S. D., et al.
Publicado: (1998)

Risk Factors for Failure of Direct Current Cardioversion in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation
por: Soran, Handrean, et al.
Publicado: (2018)

Prediction of ineffective elective cardioversion of atrial fibrillation: a retrospective multi-center patient cohort study
por: Hellman, Tapio, et al.
Publicado: (2017)

Pharmacological cardioversion for atrial fibrillation and flutter
por: Cordina, J, et al.
Publicado: (2006)

Atrial fibrillation cardioversion following acupuncture
por: Dilber, Dario, et al.
Publicado: (2015)

Rivaroxaban in atrial fibrillation cardioversion: an update
por: Lavalle, Carlo, et al.
Publicado: (2019)

How to Optimize Cardioversion of Atrial Fibrillation
por: Airaksinen, K. E. Juhani
Publicado: (2022)

Croatia needs a registry of patients undergoing direct current cardioversion for persistent atrial fibrillation/flutter
por: Dubravčić, Mia, et al.
Publicado: (2016)

A Cardioversion and Renal Dysfunction Cascade: Cardioversion for Atrial Fibrillation, Acute Kidney Injury, and Recurrence of Atrial Fibrillation
por: Asemota, Iriagbonse R, et al.
Publicado: (2020)

Left atrial emptying fraction determined during atrial fibrillation predicts maintenance of sinus rhythm after direct current cardioversion in patients with persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

A Suspected Case of Acute Embolic Myocardial Infarction Following Direct-Current Cardioversion of Atrial Fibrillation
por: Nuqali, Abdulelah, et al.
Publicado: (2018)

The RITMIA™ Smartphone App for Automated Detection of Atrial Fibrillation: Accuracy in Consecutive Patients Undergoing Elective Electrical Cardioversion
por: Reverberi, Claudio, et al.
Publicado: (2019)

Prolonged asystole following direct-current cardioversion for atrial flutter.
por: McMullan, R., et al.
Publicado: (2001)

Timing of cardioversion in atrial fibrillation: the sooner the better?
por: Capranzano, Piera, et al.
Publicado: (2020)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

SAFETY AND EFFICACY OF SAME-DAY ELECTIVE CORONARY ANGIOGRAPHY AND SYNCHRONIZED CARDIOVERSION IN PATIENTS WITH ATRIAL FIBRILLATION WITH UNINTERRUPTED ANTICOAGULATION
por: Gallen, Rory, et al.
Publicado: (2021)

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients
por: Adedara, Victor O, et al.
Publicado: (2023)

Chemical Cardioversion of Atrial Fibrillation with Calcium Gluconate
por: Serhat, A, et al.
Publicado: (2012)

Ogilvie's Syndrome following Cardioversion for Atrial Fibrillation
por: Al-Halawani, Moh'd, et al.
Publicado: (2014)

Defining the benefit: Cardioversion of persistent atrial fibrillation
por: Nedios, Sotirios, et al.
Publicado: (2021)

Outcome Analysis in Elective Electrical Cardioversion of Atrial Fibrillation Patients: Development and Validation of a Machine Learning Prognostic Model
por: Nuñez-Garcia, Jean C., et al.
Publicado: (2022)

Diurnal QT analysis in patients with sotalol after cardioversion of atrial fibrillation
por: Lenhoff, Hanna, et al.
Publicado: (2021)

Serological Predictors for the Recurrence of Atrial Fibrillation After Electrical Cardioversion
por: Kim, Sook Kyoung, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5s2m0bd715mbducaqch4p10sp3